CORT vs ZTS · P/E 199, rev $421.1M vs P/E 25, rev $2.47B
Corcept Therapeutics Incorporated (CORT) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CORT revenue for 2026-06-30 was $421.1M. Net income was $11.2M. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the CORT and ZTS stock pages for the full models.
Not investment advice.